AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2015
Jun 19, 2015
10216_dirs_2015-06-19_b14b476f-2073-412b-a3b0-8727162382af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-06-17
Reporting Person: Zhou Rong (EVP, Production)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-17 | Common Stock | S | 1000 | $16.48 | Disposed | 26232 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 99668 | Indirect |
| Common Stock | 5000 | Indirect |
Footnotes
F1: The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
F2: The shares are held of record by the reporting person's spouse.
More from Amphastar Pharmaceuticals, Inc.
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17